Sodium–glucose cotransporter 2 inhibitors and anemia among diabetes patients in real clinical practice

AIMS/INTRODUCTION: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) were reported to increase hemoglobin levels in short‐term clinical trials. Whether it is also true in real clinical practice is unknown. MATERIALS AND METHODS: This is a retrospective cohort study. Inclusion criterion was diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Murashima, Miho, Tanaka, Tomohiro, Kasugai, Takahisa, Tomonari, Tatsuya, Ide, Atsuki, Ono, Minamo, Mizuno, Masashi, Suzuki, Taisei, Hamano, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017638/
https://www.ncbi.nlm.nih.gov/pubmed/34797947
http://dx.doi.org/10.1111/jdi.13717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017638/
https://www.ncbi.nlm.nih.gov/pubmed/34797947
http://dx.doi.org/10.1111/jdi.13717

Ejemplares similares